ENDRA Life Sciences
NDRA
8 hedge funds and large institutions have $385K invested in ENDRA Life Sciences in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
24% less capital invested
Capital invested by funds: $507K → $385K (-$122K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$47.5K |
| 2 |
JP Morgan Chase
New York
|
+$6.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$67.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$8.75K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$24 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $114K | – | – | – |
|
|
NA
2
NewEdge Advisors
New Orleans,
Louisiana
| $74.6K | – | – | – |
|
|
3
Morgan Stanley
New York
| $58.9K | -$67.9K | -10 | -40% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $42.9K | – | – | – |
|
5
Dimensional Fund Advisors
Austin,
Texas
| $35.3K | – | – | – |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $28.7K | +$47.5K | +7 | New |
|
|
7
JP Morgan Chase
New York
| $16.2K | +$6.79K | +1 | +33% |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $10.3K | – | – | – |
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
CWM
10
Cranbrook Wealth Management
Bloomfield Hills,
Michigan
| $623 | – | – | – |
|
|
WAM
11
Worth Asset Management
Dallas,
Texas
| $618 | – | – | – |
|
12
BlackRock
New York
| $236 | – | – | – |
|
13
Wells Fargo
San Francisco,
California
| $50 | – | – | – |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$8.75K | -1 | Closed |
|
|
15
Bank of America
Charlotte,
North Carolina
| – | -$24 | – | – |
|
NDRA Hedge Fund Activity: Q1 2023 in Review
8 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q1 2023, worth a combined $385K — down 24% from $507K a quarter earlier.
Fund positioning in NDRA was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $47.5K. The largest seller was Morgan Stanley, cutting an estimated $67.9K.
- 8 institutional investors held ENDRA Life Sciences (NDRA) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $385K of ENDRA Life Sciences stock for Q1 2023, down 24% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest ENDRA Life Sciences buyer in Q1 2023 was Susquehanna International Group, an estimated $47.5K added.
- The largest ENDRA Life Sciences seller in Q1 2023 was Morgan Stanley, an estimated $67.9K sold.
Based on aggregated 13F filings for Q1 2023.